Literature DB >> 27798287

Altered T-Cell Balance in Lymphoid Organs of a Mouse Model of Colorectal Cancer.

Scott M Tanner1,2, Joseph G Daft3, Stephanie A Hill4, Colin A Martin2, Robin G Lorenz4.   

Abstract

The adenomatous polyposis coli (APC) gene is a known tumor suppressor gene, and mice with mutations in Apc (ApcMin/+) spontaneously form multiple intestinal neoplasms. In this model of human colorectal cancer (CRC), it has been reported that CD4+ T-cell-derived interleukin 17 (IL-17) promotes intestinal tumor development, but it is not known if the Apc mutation actually directly alters T-cell function and subsequently tumor immunosurveillance. To investigate the ApcMin/+ mutation on T-cell function, flow cytometric, histochemical, and immunofluorescent studies on both wild-type (Apc+/+) and ApcMin/+ mice were performed. We identified decreased levels of interferon gamma (IFN-γ+)IL-17+ double-positive CD4+ cells in the mesenteric lymph nodes and Peyer's patches of ApcMin/+ mice. In addition, altered levels of CD8+ cells, and changes in CD8+ production of IFN-γ and granzyme B were observed. These T-cell alterations did modify tumor immunosurveillance, as the adoptive transfer of splenocytes from ApcMin/+ animals into a chemically induced CRC model resulted in the inability to prevent epithelial dysplasia. These results suggest an altered T-cell balance in ApcMin/+ mice may disrupt intestinal homeostasis, consequently limiting intestinal tumor immunosurveillance.
© 2016 The Histochemical Society.

Entities:  

Keywords:  CD4; CD8; T cell; colorectal cancer; interferon gamma; interleukin 17; mouse model; mucosal immunity; tumor immunosurveillance

Mesh:

Substances:

Year:  2016        PMID: 27798287      PMCID: PMC5131745          DOI: 10.1369/0022155416672418

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  24 in total

1.  Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.

Authors:  Atsushi Kajiwara; Hiroyoshi Doi; Junichi Eguchi; Shigeaki Ishii; Ayako Hiraide-Sasagawa; Masashi Sakaki; Risa Omori; Kazumasa Hiroishi; Michio Imawari
Journal:  Oncol Rep       Date:  2012-03-15       Impact factor: 3.906

2.  Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis.

Authors:  S M Tanner; E M Staley; R G Lorenz
Journal:  Mucosal Immunol       Date:  2012-08-08       Impact factor: 7.313

3.  Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.

Authors:  Wook-Jin Chae; Thomas F Gibson; Daniel Zelterman; Liming Hao; Octavian Henegariu; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

Review 4.  Application of the Apc(Min/+) mouse model for studying inflammation-associated intestinal tumor.

Authors:  Lu Wang; Qingzhu Zhang
Journal:  Biomed Pharmacother       Date:  2015-02-24       Impact factor: 6.529

Review 5.  Familial adenomatous polyposis.

Authors:  Polymnia Galiatsatos; William D Foulkes
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice.

Authors:  Shaojin You; Masami Ohmori; Maria Marjorette O Peña; Basel Nassri; Jovelyn Quiton; Ziad A Al-Assad; Lucy Liu; Patricia A Wood; Sondra H Berger; Zhijian Liu; Michael D Wyatt; Robert L Price; Franklin G Berger; William J M Hrushesky
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

7.  A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth.

Authors:  Ni Hou; Xin Zhang; Lingyu Zhao; Xiaoge Zhao; Zongfang Li; Tusheng Song; Chen Huang
Journal:  Biochem Biophys Res Commun       Date:  2013-09-10       Impact factor: 3.575

8.  Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis.

Authors:  P Louise Coletta; Albrecht M Müller; Elena A Jones; Bettina Mühl; Sarah Holwell; Deborah Clarke; Josephine L Meade; Graham P Cook; Gillian Hawcroft; Frederique Ponchel; Wai K Lam; Ken A MacLennan; Mark A Hull; Constanze Bonifer; Alexander F Markham
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

Review 9.  Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy.

Authors:  Keishi Adachi; Koji Tamada
Journal:  Cancer Sci       Date:  2015-07-02       Impact factor: 6.716

Review 10.  Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance.

Authors:  Scott Nelson; Inke S Näthke
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

View more
  3 in total

1.  An increased CD25-positive intestinal regulatory T lymphocyte population is dependent upon Cox-2 activity in the Apcmin/+ model.

Authors:  O O Faluyi; P Fitch; S E M Howie
Journal:  Clin Exp Immunol       Date:  2017-10-24       Impact factor: 4.330

Review 2.  The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.

Authors:  Aldona Kasprzak
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

3.  IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways.

Authors:  Yang Song; Ming Yang; Hongjian Zhang; Yan Sun; Ye Tao; Huihui Li; Jing Zhang; Yuncheng Li; Jianming Yang
Journal:  J Immunol Res       Date:  2020-12-18       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.